What can we achieve with novel mass spectrometry techniques?

During the 63rd ASH Annual Meeting and Exposition, the Multiple Myeloma Hub was pleased to speak to María-Victoria Mateos, University...

Daratumumab as maintenance therapy for transplant-eligible patients with NDMM: What have we learned from GRIFFIN and CASSIOPEIA trials?

During the 63rd ASH Annual Meeting and Exposition, the Multiple...

Dara-(C)VRd pre- and post-ASCT for ultra-high risk MM and primary plasma cell leukemia

Patients with newly diagnosed multiple myeloma (NDMM) are currently treated largely using similar regimens...

EMN recommendations for COVID-19 vaccination in patients with MM

Multiple myeloma (MM) and other monoclonal gammopathies can increase patient susceptibility to infection, either as a direct result of...

EMN recommendations for COVID-19 vaccination in patients with MM

Multiple myeloma (MM) and other monoclonal gammopathies can increase patient susceptibility to infection, either as a direct result of...

Humoral and cellular responses in patients with lymphoid malignancies receiving SARS-Cov-2 vaccination

Factors that influence the efficacy of Severe Acute Respiratory Syndrome Coronavirus-2...

COVID-19 lessons learnt in patients with multiple myeloma

During the 18th International Myeloma Workshop, Evangelos Terpos provided a summary of what has been learnt with respect to patients with...

IMWG clinical practice guidelines for the treatment of multiple myeloma-related bone disease

After evaluating the existing literature and grading recommendations using the Grading of Recommendations,...

FDA lifts clinical hold on allogeneic CAR T cell therapy trials

On January 10, 2022, the U.S. Food and Drug Administration (FDA) lifted the clinical hold across all trials investigating allogeneic...

Life after CAR-T: Clinical outcomes of patients with MM who relapse after BCMA-targeted CAR T-cell therapy

At the 2021 International Myeloma Workshop (IMW21) in September, Oliver Van Oekelen, from the...

EMN recommendations for COVID-19 vaccination in patients with MM

Multiple myeloma (MM) and other monoclonal gammopathies can increase patient susceptibility to infection, either as a direct result of...

ASH 2021 abstracts: What’s hot in multiple myeloma?

To help navigate the exciting content being presented at the 63rd ASH Annual Meeting and Exposition, the Multiple Myeloma Hub Steering Committee...